What is the best approach to switch a patient from Lexapro (escitalopram) to Prozac (fluoxetine)? | Rounds What is the best approach to switch a patient from Lexapro (escitalopram) to Prozac (fluoxetine)? | Rounds
Loading...

What is the best approach to switch a patient from Lexapro (escitalopram) to Prozac (fluoxetine)?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Switching Escitalopram to Fluoxetine

Direct switching from escitalopram (an SSRI) to fluoxetine (another SSRI) is normally possible by stopping escitalopram and starting fluoxetine the following day. [1]

Medication Selection Algorithm

  • SSRI to another SSRI (including escitalopram → fluoxetine): direct switch is normally possible. [1]

Switching Method

  • Direct switch: escitalopram is stopped, and fluoxetine is started the following day. [1]
  • Cross-tapering is not described as routinely necessary for this SSRI-to-SSRI switch in the available switching guidance. [1]

Initiation Thresholds and Timing

  • The new SSRI is started the following day after stopping the current SSRI. [1]

Important Clarifications and Nuances

  • Additional precautions may be required when changing antidepressants in the setting of increased adverse-effect risk or complex comorbidity, since switching strategies are individualized to tolerability and safety monitoring needs. [1]

Common Pitfalls to Avoid

  • Serotonin toxicity risk increases with unnecessary overlap strategies (particularly with switches that are not considered direct SSRI-to-SSRI transitions). [1]
  • Incomplete discontinuation of escitalopram while fluoxetine is initiated without a direct-switch plan can create unintended SSRI overlap. [1]

Target Therapeutic Monitoring Goals

  • Monitoring should focus on recurrence of depressive symptoms and emergence of SSRI adverse effects during the transition period. [1]

Patient Safety Monitoring During Transition

  • Monitoring should include assessment for adverse effects consistent with SSRIs and for discontinuation-emergent symptoms after stopping escitalopram. [1]

Related Questions